
Copan Diagnostics manufactures transport systems for pathogenic biological vectors.
Founded with a mission to enhance the quality and reliability of specimen collection and transport, Copan Diagnostics specializes in manufacturing transport systems for pathogenic biological vectors, such as bacteria and viruses. The company offers a wide range of products including FLOQSwabs®, UTM®, ESwab®, and various laboratory supplies designed for efficient sample collection, transport, and processing. Copan Diagnostics serves the healthcare, pharmaceutical, and food safety markets, focusing on innovations that improve diagnostic accuracy and patient outcomes.
Notable figures associated with Copan Diagnostics include experts in microbiology and infectious diseases who contribute to the company's product development and research initiatives. The company has achieved significant milestones, such as the widespread adoption of its FLOQSwabs® in clinical settings globally. Copan Diagnostics' impact is evident in its contribution to more accurate diagnostics and streamlined laboratory workflows, reinforcing its reputation as a leader in specimen collection and transport solutions.

Accelerate Diagnostics

Co-Diagnostics
co-dx.com

Empowered Diagnostics

Specific Diagnostics

Kepler Diagnostics
keplerdx.com

PathogenDx
pathogendx.com

GeneCapture
genecapture.com

Cobio Diagnostics
cobio.co

Erba Diagnostics

Quest Diagnostics

EKF Diagnostics
ekfdiagnostics.com

Rapid Diagnostek

Test Diagnostics

Instadiagnostics

Nowdiagnostics
nowdx.com
Companies similar to Copan Diagnostics include Accelerate Diagnostics, Co-Diagnostics, Empowered Diagnostics and Specific Diagnostics.
Copan Diagnostics was founded in 1994.
Copan Diagnostics' headquarters is located in Murrieta, CA, US.
Copan Diagnostics' most recent funding round was for $10M (USD) in May 2020.
As of May 7, 2020, Copan Diagnostics has raised a total of $10M (USD).
Copan Diagnostics has 47 employees as of Feb 4, 2024.